JK Aronson

1.9k total citations
25 papers, 458 citations indexed

About

JK Aronson is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, JK Aronson has authored 25 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 7 papers in Psychiatry and Mental health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in JK Aronson's work include Pharmacological Effects and Toxicity Studies (8 papers), Electrolyte and hormonal disorders (6 papers) and Pharmaceutical studies and practices (6 papers). JK Aronson is often cited by papers focused on Pharmacological Effects and Toxicity Studies (8 papers), Electrolyte and hormonal disorders (6 papers) and Pharmaceutical studies and practices (6 papers). JK Aronson collaborates with scholars based in United Kingdom and Australia. JK Aronson's co-authors include DG Grahame‐Smith, S. C. Truelove, R E Ferner, HF Woods, Christopher D. Buckley, AR Green, G. Curzon, Fredrick M. Wigley, AJ Wood and Charlie Harper and has published in prestigious journals such as The Lancet, BMJ and British Journal of Clinical Pharmacology.

In The Last Decade

JK Aronson

24 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JK Aronson United Kingdom 12 144 85 78 60 60 25 458
M. M. Reidenberg United States 12 133 0.9× 62 0.7× 80 1.0× 70 1.2× 51 0.8× 27 659
Klaus D. Raemsch Germany 6 61 0.4× 75 0.9× 90 1.2× 54 0.9× 33 0.6× 8 376
Dennis J. Chapron United States 12 88 0.6× 86 1.0× 27 0.3× 72 1.2× 81 1.4× 22 431
E. Nüesch Japan 13 93 0.6× 53 0.6× 45 0.6× 74 1.2× 49 0.8× 25 579
K F Ilett Australia 10 106 0.7× 135 1.6× 32 0.4× 52 0.9× 22 0.4× 22 568
Niels Anders Klitgaard Denmark 13 73 0.5× 114 1.3× 204 2.6× 48 0.8× 70 1.2× 24 570
Howard Warner United States 6 99 0.7× 51 0.6× 242 3.1× 56 0.9× 40 0.7× 10 521
Henry J. Pfeifer United States 7 89 0.6× 48 0.6× 116 1.5× 71 1.2× 51 0.8× 10 358
R. Calvo Spain 14 83 0.6× 88 1.0× 32 0.4× 65 1.1× 28 0.5× 47 538
Nahoko Kurosawa Japan 11 67 0.5× 84 1.0× 46 0.6× 33 0.6× 28 0.5× 30 427

Countries citing papers authored by JK Aronson

Since Specialization
Citations

This map shows the geographic impact of JK Aronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JK Aronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JK Aronson more than expected).

Fields of papers citing papers by JK Aronson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JK Aronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JK Aronson. The network helps show where JK Aronson may publish in the future.

Co-authorship network of co-authors of JK Aronson

This figure shows the co-authorship network connecting the top 25 collaborators of JK Aronson. A scholar is included among the top collaborators of JK Aronson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JK Aronson. JK Aronson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glasziou, Paul & JK Aronson. (2018). A brief history of clinical evidence updates and bibliographic databases. Journal of the Royal Society of Medicine. 111(8). 292–301. 2 indexed citations
2.
Aronson, JK. (2016). “Collaborative care” is preferable to “patient centred care”. BMJ. 353. i2926–i2926. 6 indexed citations
3.
Ferner, R E & JK Aronson. (2000). Medication errors, worse than a crime. The Lancet. 355(9208). 947–948. 43 indexed citations
4.
Buckley, Christopher D. & JK Aronson. (1995). Prolonged half‐life of verapamil in a case of overdose: implications for therapy.. British Journal of Clinical Pharmacology. 39(6). 680–683. 24 indexed citations
5.
Aronson, JK, et al.. (1991). Intravenous strontium gluconate as a kinetic marker for calcium in healthy volunteers.. British Journal of Clinical Pharmacology. 31(4). 423–427. 7 indexed citations
7.
Wood, AJ, et al.. (1990). The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers.. British Journal of Clinical Pharmacology. 30(3). 383–390. 3 indexed citations
8.
Wood, AJ, JK Aronson, C Bunch, & DG Grahame‐Smith. (1989). A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.. British Journal of Clinical Pharmacology. 27(6). 749–756. 5 indexed citations
9.
Aronson, JK, et al.. (1986). In vivo cation transport during short‐term and long‐term digoxin therapy.. British Journal of Clinical Pharmacology. 22(1). 27–30. 1 indexed citations
10.
Aronson, JK, et al.. (1983). Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.. British Journal of Clinical Pharmacology. 15(6). 727–734. 12 indexed citations
11.
Truelove, S. C., et al.. (1982). The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.. British Journal of Clinical Pharmacology. 13(4). 523–528. 103 indexed citations
12.
Aronson, JK, et al.. (1981). Lack of effect of phenytoin on functions related to Na+,K+‐ATPase activity of the intact erythrocytes of epileptic patients.. British Journal of Clinical Pharmacology. 12(1). 79–81. 1 indexed citations
13.
Green, AR, JK Aronson, G. Curzon, & HF Woods. (1980). Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol.. British Journal of Clinical Pharmacology. 10(6). 611–615. 5 indexed citations
14.
Green, AR, JK Aronson, G. Curzon, & HF Woods. (1980). Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.. British Journal of Clinical Pharmacology. 10(6). 603–610. 43 indexed citations
17.
Aronson, JK, et al.. (1979). The characteristics of the binding of 12‐alpha‐[3H]‐digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.. British Journal of Clinical Pharmacology. 8(2). 115–124. 23 indexed citations
18.
Aronson, JK. (1978). Monitoring digoxin therapy: III. How useful are the nomograms?. British Journal of Clinical Pharmacology. 5(1). 55–64. 15 indexed citations
19.
Aronson, JK & DG Grahame‐Smith. (1977). Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.. British Journal of Clinical Pharmacology. 4(2). 223–227. 20 indexed citations
20.
Aronson, JK, et al.. (1977). Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.. British Journal of Clinical Pharmacology. 4(2). 213–221. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026